Keiji Mogi

Elixirgen Therapeutics, Inc. operates as a biotechnology company. It develops and sells stem cell therapies for genetic diseases. The company was founded by Akihiro Ko and Minoru S. H. Ko in 2017 and is headquartered in Baltimore, MD.

Algal Bio Co., Ltd. engages in the development, production and sale of algae and its components. The company was founded by Tsuyoshi Takeshita on March 1, 2018 and is headquartered in Kashiwa, Japan.

AiDi Corp. offers passive optical network products and services. It offers marketing and technical services. The firm products include PLC splitters, fiber arrays, hermetic feedthrough assemblies, optical test equipment and miscellaneous products. The company was founded by Kenzo Ishida in 2004 and is headquartered in Tsukuba, Japan.

Globis Capital Partners & Co. (GCP) is a Private Equity/Venture Capital firm, a subsidiary of Globis Corp. founded in 1996 by Soichi Kariyazono.The firm is headquartered in Tokyo.

Adacotech, Inc. is a Japanese company that specializes in the research, development, manufacture, and sales of systems related to video surveillance and automatic recognition. The company is based in Tokyo, Japan. The company was founded in 2012. Ryota Kawamura has been the CEO of the company since 2019.

Provigate KK engages in the development, manufacture and sale of blood glucose level measuring instrument. The company was founded in March 2015 and is headquartered in Tokyo, Japan.

Jefferies (Japan) Ltd. (JJ) is the Tokyo branch and subsidiary of US-based Jefferies Asia Holdings II Pte Ltd., ultimately held by Leucadia National Corp. (NYSE: LUK) in the US. Established in 1996, the firm focuses on Asian markets and provides brokerage and investment banking services to institutional and corporate clients located primarily in Asia and the Middle East. Their activities include sales and trading of Japanese equity, equity-linked and structured products, the distribution of equity research and execution services in cooperation with US and European offices and the provision of electronic connectivity throughout Asia. They issue equity shares through GDRs and ADRs, and are a leading issuer of convertible bonds, high-yield in particular. In-house research covers a variety of industries including the maritime sector, infrastructure, logistics, outsourcing, technology and IT. In addition to Japan, JJ focuses on countries such as China and India, providing a range of services to Chinese and Indian companies, including access to international equity and debt capital markets, securities underwriting, US public and private offerings and cross-border M&A advisory. They also cooperate with private equity and venture capital firms focused on the Chinese and Indian markets.

Molcure, Inc. operates as a antibody-drug-focused biopharmaceutical company. It develops systems and technologies that enable pharmaceutical companies (developing antibody drugs) to identify antibody candidates. It offers Abtracer, an antibody sequence screening system to detect antibodies; and SmartLabModule, an IoT platform for science. The company was founded by Eli Lyons, Ryu Ogawa, Yoichiro Hara and Yutaro Kyono on May 1, 2013 and is headquartered in Tokyo, Japan.

Quantum Biosystems, Inc. is a holding company that develops single-molecule DNA sequencers. It develops and commercializes sequencers based on quantum mechanics. The company was founded by Toshihiko Honkura and Masateru Taniguchi on January 7, 2013 and is headquartered in Osaka, Japan.

The Housing Finance Corp. Ltd. provides housing loans. It makes loans to borrowers and funds itself through the issue of bonds. The company was founded in 1987 and is headquartered in London, the United Kingdom.

Goldman Sachs Japan Co., Ltd. (GSJCL) is the Japan-based broker-dealer subsidiary of Goldman Sachs (Japan) Ltd., ultimately held by The Goldman Sachs Group, Inc. (NYSE: GS) in the US. The firm originated in 1974 and was formally founded in 1983. Headquartered in Tokyo, GSJCL offers Internet-based transaction services covering equity, debt, commodities and derivatives to a substantial and diversified client base, which includes corporations, financial institutions, governments and high net worth individuals.

HashPort, Inc. provides blockchain technology and investment solutions. The company is based in Tokyo, Japan. The Japanese company was founded in 2018 by Seihaku Yoshida. Seihaku Yoshida has been the CEO since 2018.

Part of HashPort, Inc., Fressets, Inc. engages in research and development of technology of cryptocurrency and blockchain. The company is based in Bunkyo-ku, Japan. The Japanese company was founded in 2017 by Masahiko Hyuga. The CEO is Yosuke Yunoki. Fressets was acquired by HashPort, Inc. on March 01, 2021.

Socium, Inc. provides drug development and research services. It deals with drug rescue and repositioning, biomarker identification, and mechanism of action research. The company was founded by Manabu Takahashi and Katsuhisa Horimoto in September 2017 and is headquartered in Tokyo, Japan.

MONEY DESIGN Co., Ltd. engages in investment management and investment advisory services. It also involves in agency business, first class financial instruments and defined contribution pension operation & management business. The company was founded by Mamoru Taniya and Tomoyoshi Hirose on August 1, 2013 and is headquartered in Tokyo, Japan.

ASM, Inc. is a holding company that provides research, development, and commercialization of Polyrotaxanes. Its product, the SeRM Super Polymer, is a raw polymeric material with improved solubility in solvents, compatibility with other materials for use in other industrial applications. The firm's solution can be used in applications including coating materials and inks, elastomer, and adhesives. The company was founded on March 1, 2005 and is headquartered in Kashiwa, Japan.

Noxilizer, Inc. engages in the provision of room temperature nitrogen dioxide sterilization technology. It sells sterilization equipment and biodecontamination equipment to pharmaceutical, biotech, and medical device manufacturers and also offers contract sterilization services. The company was founded in 2004 and is headquartered in Baltimore, MD.

popIn, Inc. engages in web browser development. One of its products is READ, a service that analyzes how long a viewer stays on a particular website. It also offers a personalized content recommendation service. The company was founded by Tao Cheng and Tei Tou on July 7, 2008 and is headquartered in Tokyo, Japan.

Wood Plastic Technology Co., Ltd. engages in the business of manufacturing and sale of wood plastic products and raw materials. Its products include Pallet, W board, Gravel fixture and others. The company was founded by Naoto Ando on February 4, 2008 and is headquartered in Kurayoshi, Japan.

UK Atomic Energy Authority operates as a holding company with interest in nuclear clean-up services. The firm's subsidiary UKAEA Limited provides services under contract in both the UK and overseas. The company was founded in 1954 and is headquartered in Didcot, UK.

Brighton Dome & Festival Ltd. is a multi-arts venue that believes in the power of the arts to inspire and change lives for the better. The non-profit company is based in Brighton, UK and is housed in a beautiful Grade listed building. The British company has recently launched livestreams featuring celebrated authors, actors, and podcasters that can be enjoyed from the comfort of one's own home. The CEO of the company is Andrew Comben.

Seaos, Inc. engages in logistics strategy consulting and operation and application software and robot development. The company was founded by Akira Matsushima on August 1, 2000 and is headquartered in Tokyo, Japan.

GLM Co., Ltd. develops, produces, and sells eco- friendly cars. It also offers services related to the production of vehicles. Its products include sports cars under the brand name Tommy Kaira ZZ and GLM G4. The company was founded by Hiroyasu Koma in April 2010 and is headquartered in Kyoto, Japan.

Part of Sun Metalon KK, Sun Metalon Inc. is developing a new principle-based metal 3D printer that can reduce costs by more than 90% due to ultra-high efficiency. The company is based in Redondo Beach, CA. The first machine is scheduled for official release in early 2023, with the size of parts that can be manufactured expanding in stages. Three machine lineups will be taken to the market as of 2023. Sun Metalon will be exhibiting at the following trade shows in Japan and Germany: Jimtof2022 (Tokyo, November 8-13) and Formnext 2022 (Frankfurt am Main, November 15-18). The company was founded by Kazuhiko Nishioka, Kei Takizawa, Koji Kageyama, Yuki Maeda, with Kazuhiko Nishioka serving as the CEO since incorporation.

Vision Super Pty Ltd. is an Australian company that prioritizes its members by providing them with strong investment returns, low fees, and a sustainable focus. The private company is based in Melbourne, Australia. and has subsidiaries in Australia. The company was founded in 1947. Stephen Rowe has been the CEO of the company since 2013.

Part of Société Générale SA, Société Générale Asset Management is a leading European asset manager based in Paris la Defense, France. The French company offers a complete range of savings and investment solutions in active and passive management, in traditional or real assets. Amundi, the company's parent, ranks among the top 10 players and serves over 100 million clients including retail, institutional, and corporate customers.

TCW Europe Ltd. provides investment management services. The private company is based in London, UK and was founded in 2013.

Part of SIPCO Holdings Ltd., Investcorp Europe Holdings Ltd. is a British company that provides alternative investment management services. The company is based in London, UK. Investcorp Europe Holdings was founded in 2017.

Peach Tech Ltd. operates as a car dealer. The company is located in Kenya.

TXP Medical, Inc. specializes in providing patient information record and management systems for emergency hospitals. TXP Medical is based in Japan and was founded in 2017 by Tomohiro Sono. The Japanese company's products include Next Stage ER, a paperless system for efficient patient information records and information sharing among staff, Next Stage Oncology, a database system that improves the speed and quality of medical treatment and research, NSER Mobile, an emergency support app that digitizes emergency patient information and links information in the cloud, and an interview system that allows for collaboration and incorporation of electronic medical records. The company also offers a clinic and hospitalization support system for corona-infected patients and an acute clinical trial support service for pharmaceuticals and medical device manufacturers. The company has a rare research system that includes an academic research department gathering students and doctors from all over the country.

MiRTeL Co. Ltd. engages in the business of gene testing services. Its services include research and development of health diagnostic systems; clinical examination and health related materials to medical care; sale of medical devices; clinical testing and clinical diagnostic services; planning of medical and information systems related to clinical testing; manufacturing, sale, import and export of pharmaceutical products and health foods; collection and delivery of reagents, containers and materials; manufacture and sale of DNA measuring kits; and all types of businesses related to clinical laboratories. The company was founded on September 3, 2012 and is headquartered in Hiroshima, Japan.

The Japanese company has a wealth of experience in micro-biome research and have obtained high-quality microbial genome data from various samples. The company is based in Tokyo, Japan. The company strategically combines their own single-cell analysis technology, bit-map®, to realize the next-generation microbiome analysis that approaches the essence of microbial functions. The company also uses the microbial genomic information owned by bitBiome to provide new knowledge for research and development promoted by joint partners and customers. The company was founded by Yoshihito Daimon, Masahito Hosokawa. Kimihiko Sato has been the CEO of the company since 2020.

Editforce, Inc. engages in research, development and production of medicinal drugs. The company is headquartered in Fukuoka, Japan.